CEROW
Income statement / Annual
Last year (2024), CERo Therapeutics Holdings, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, CERo Therapeutics Holdings, Inc.'s net income was -$7.73 M.
See CERo Therapeutics Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.16 M
|
$1.12 M
|
$0.00
|
$0.00
|
| Gross Profit |
-$1.16 M
|
-$1.12 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.32 M
|
$0.00
|
$9.85 M
|
$9.14 M
|
| General & Administrative Expenses |
$8.99 M
|
$2.89 K
|
$2.13 M
|
$2.48 M
|
| Selling & Marketing Expenses |
$0.00
|
$2.89 M
|
$715.76 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.99 M
|
$2.89 M
|
$2.84 M
|
$2.48 M
|
| Other Expenses |
$351.00
|
$40.05 K
|
-$9.78 M
|
-$11.18 M
|
| Operating Expenses |
$15.30 M
|
$2.93 M
|
$2.91 M
|
$431.50 K
|
| Cost And Expenses |
$15.30 M
|
$2.93 M
|
$2.91 M
|
$332.03 K
|
| Interest Income |
$26.65 K
|
$138.34 K
|
$2.84 M
|
$986.71 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.16 M
|
$2.93 K
|
$2.91 M
|
$735.47 K
|
| EBITDA |
-$6.57 M |
-$2.44 M |
-$68.58 K |
$403.06 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$7.57 M
|
$491.57 K
|
$2.84 M
|
-$385.00
|
| Income Before Tax |
-$7.73 M
|
-$2.44 M
|
-$68.58 K
|
-$332.42 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$94.82 K
|
$599.16 K
|
-$16.87 K
|
| Net Income |
-$7.73 M
|
-$2.54 K
|
-$667.74 K
|
-$315.55 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-6.87 |
-2497.2 |
-19.73 |
-2.75 |
| EPS Diluted |
-6.87 |
-2497.2 |
-19.73 |
-2.75 |
| Weighted Average Shares Out |
$1.21 M
|
$2.92 K
|
$33.84 K
|
$114.90 K
|
| Weighted Average Shares Out Diluted |
$1.21 M
|
$2.92 K
|
$33.84 K
|
$114.90 K
|
| Link |
|
|
|
|
